Daily Intraperitoneal Administration of Rosiglitazone Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia

• मुख्य लेखकों: Giorgio Aquila (लेखक), Yannick Regin (लेखक), Xabier Murgia (लेखक), Fabrizio Salomone (लेखक), Costanza Casiraghi (लेखक), Chiara Catozzi (लेखक), Enrica Scalera (लेखक), Matteo Storti (लेखक), Francesca Stretti (लेखक), Giancarlo Aquino (लेखक), Giorgia Cavatorta (लेखक), Roberta Volta (लेखक), Carmelina Di Pasquale (लेखक), Caterina Amato (लेखक), Fabio Bignami (लेखक), Davide Amidani (लेखक), Barbara Pioselli (लेखक), Elisa Sgarbi (लेखक), Paolo Ronchi (लेखक), Giuseppe Mazzola (लेखक), Ignacio Valenzuela (लेखक), Jaan Toelen (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2022-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Thiazolidinediones (TZDs) are potent PPARγ agonists that have been shown to attenuate alveolar simplification after prolonged hyperoxia in term rodent models of bronchopulmonary dysplasia. However, the pulmonary outcomes of postnatal TZDs have not been investigated in preterm animal models. Here, we...